Wednesday, November 6, 2024
HomeTagsVivaVision Biotech

VivaVision Biotech

VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye Disease

VivaVision Biotech, Inc., an ophthalmic pharmaceutical developer focusing on discovery and development of innovative therapies for ocular diseases, announced positive topline results from a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics